Evidence map›Paper›PMID 16283483›Full record

ArticleClinical & experimental metastasis2005

MRI detection of early bone metastases in b16 mouse melanoma models.

Karen M Gauvain, Joel R Garbow, Sheng-Kwei Song, Angela C Hirbe, Katherine Weilbaecher

Open access · greenAbstract read
In one paragraph

Article in Clinical & experimental metastasis, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Animal cancer models of skeletal metastasis.Cancer growth and metastasis · 2013
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. FDG small animal PET permits early detection of malignant cells in a xenograft murine model.European journal of nuclear medicine and molecular imaging · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Karen M GauvainDepartment of Pediatrics, Division of Hematology/Oncology, Washington University School of Medicine, One Children's Place, Box 8116, St. Louis, MO 63110, USA. Gauvain_k@kids.wustl.edu
Joel R Garbow
Sheng-Kwei Song
Angela C Hirbe
Katherine Weilbaecher
St. Louis Children's Hospital · USMolecular Oncology (United States) · USWashington University in St. Louis · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
WASHINGTON UNIVERSITY SMALL ANIMAL IMAGING RESOURCER24CA083060 · NCI · WASHINGTON UNIVERSITY · PI ACKERMAN, JOSEPH J. H. · 1999 to 2006
$4.8M
ROLE OF BETA 3 INTEGRIN IN SKELETAL METASTASISR01CA097250 · NCI · WASHINGTON UNIVERSITY · PI WEILBAECHER, KATHERINE NELSON · 2003 to 2014
$3.3M
Training Program in Development HematologyT32HD007499 · NICHD · WASHINGTON UNIVERSITY · PI RUBIN, JOSHUA B · 1999 to 2019
$2.3M
NCI NIH HHS P30 CA091842NCI NIH HHS P30 CA91842NCI NIH HHS R01 CA097250NCI NIH HHS R01 CA97250NCI NIH HHS R24 CA083060NCI NIH HHS R24 CA 83060NHLBI NIH HHS 5T3 HL0708828NICHD NIH HHS T32 HD007499NICHD NIH HHS T32 HD07499
6 · The paper itself

Abstract

Bone metastasis causes significant morbidity in cancer patients, including bone pain, pathologic fractures, nerve compression syndrome, and hypercalcemia. Animal models are utilized to study the pathogenesis of skeletal metastases and to evaluate potential therapeutic agents. Previously published methods for imaging bone metastasis in rodent models have focused on identifying advanced stage metastasis using simple X-rays. Here we report MRI as a method for detecting early bone metastases in mouse models in vivo. B16 mouse melanoma cells were injected into the left cardiac ventricle of C57BL/6 mice and magnetic resonance (MR) images were obtained of the left leg following the development of metastatic disease, when tumor associated bone destruction was histologically present but not visible by X-ray. T1 and T2 relaxation times of bone marrow were measured in healthy control mice and B16 melanoma tumor-bearing mice. Mean T2 values for normal marrow were 28 ms (SD 5) and for diseased bone marrow were 41 ms (SD 3). T2 relaxation time of diseased bone marrow is significantly longer than that of normal bone marrow (P < 0.0001) and can be used as a marker of early bone metastases. These studies demonstrate that MR imaging can detect bone marrow metastases in small animals prior to development of cortical bone loss identified by X-ray.

Indexed as

AnimalsBone NeoplasmsDisease Models, AnimalMagnetic Resonance ImagingMelanomaMiceMice, Inbred C57BL

Identifiers

PMID16283483
PMCPMC2726655
OpenAlexW2079843053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.